BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND Ki-67 AND Treatment
346 results:

  • 1. Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience.
    Sukrithan V; Armbruster H; Rogers S; Vogt SM; Grenade C; Verschraegen C; Zhou Y; Goyal A; Natwa M; Hussein A; Barr H; Konate D; Batdorf R; Brown A; Williams B; Zhao S; Wei L; Xu M; Shah MH; Konda B
    PLoS One; 2024; 19(5):e0298824. PubMed ID: 38748739
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Outcome and Factors Related to Isolated liver Metastasis due to Breast cancer.
    Sen E; Canbak T; Bostanci O; Battal M
    J Coll Physicians Surg Pak; 2024 May; 34(5):604-609. PubMed ID: 38720224
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Diacylglycerol kinase alpha is a proliferation marker of intrahepatic cholangiocarcinoma associated with the prognosis.
    Shichi S; Sugiyama K; Asahi Y; Shirakawa C; Nakamoto H; Kimura S; Wakizaka K; Aiyama T; Nagatsu A; Orimo T; Kakisaka T; Taketomi A
    Cancer Med; 2024 May; 13(9):e7238. PubMed ID: 38716625
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Epithelial-Mesenchymal Transformation Promotes the Progression of Hepatocellular Carcinoma through NF-κB/MMP9 Axis.
    Li J; Cai Q; Wang Z; Wang L; Yang G; Zhang Z; Ge N; Hu S; Bai T
    Discov Med; 2024 Apr; 36(183):666-677. PubMed ID: 38665016
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. New treatment alternatives for primary and metastatic colorectal cancer by an integrated transcriptome and network analyses.
    Karaca C; Demir Karaman E; Leblebici A; Kurter H; Ellidokuz H; Koc A; Ellidokuz EB; Isik Z; Basbinar Y
    Sci Rep; 2024 Apr; 14(1):8762. PubMed ID: 38627442
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Abdominopelvic desmoplastic small round cell tumor with metastasis: A case report and literature review.
    Chen G; Zhang Q; Xia D
    Medicine (Baltimore); 2024 Apr; 103(14):e37664. PubMed ID: 38579065
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice.
    Liu Y; Guerrero DQ; Lechuga-Ballesteros D; Tan M; Ahmad F; Aleiwi B; Ellsworth EL; Chen B; Chua MS; So S
    Int J Nanomedicine; 2024; 19():2639-2653. PubMed ID: 38500681
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Predicting ki-67 expression in hepatocellular carcinoma: nomogram based on clinical factors and contrast-enhanced ultrasound radiomics signatures.
    Zhang D; Zhang XY; Lu WW; Liao JT; Zhang CX; Tang Q; Cui XW
    Abdom Radiol (NY); 2024 May; 49(5):1419-1431. PubMed ID: 38461433
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MHY1485 promotes adriamycin sensitivity in HepG2 cells by inhibiting autophagy.
    Guo J; Lei Y; Liu L; Wen Z; Zhang B; Fang J; Liang G; Guo Q; Peng J
    Funct Integr Genomics; 2024 Feb; 24(1):22. PubMed ID: 38306005
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [A Case of Triple Negative Breast cancer with Successful Control of Recurrent Disease Activity for More than Ten Years].
    Yabe N; Watanuki R; Harada Y; Kondo A; Yanagisawa T; Maeda H; Kishi M; Yoshikawa T; Osumi K; Kamiya N; Sotome K; Ishii Y; Jinno H; Ikeda T; Watanabe M
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1759-1761. PubMed ID: 38303198
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Antitumor effects of redox-responsive nanoparticles containing platinum(Ⅳ)in ovarian cancer].
    Hou HY; Tang DS; Zhang YN; Wang KY; Ao M; Luo HX; Li B
    Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):76-85. PubMed ID: 38246783
    [No Abstract]    [Full Text] [Related]  

  • 12. Efficacy, safety, and predictive model of Palbociclib in the treatment of HR-positive and HER2-negative metastatic breast cancer.
    Wang W; Lei W; Fang Z; Jiang R; Wang X
    BMC Cancer; 2024 Jan; 24(1):1. PubMed ID: 38166784
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network.
    Perrier M; Brugel M; Gérard L; Goichot B; Lièvre A; Lepage C; Hautefeuille V; Do Cao C; Smith D; Thuillier P; Cros J; Cadiot G; Walter T; de Mestier L
    Eur J Endocrinol; 2023 Dec; 189(6):575-583. PubMed ID: 38039101
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Quantitative SSTR-PET/CT for predicting response and survival outcomes in patients with pancreatic neuroendocrine tumors receiving CAPTEM.
    Ingenerf M; Karim H; Auernhammer C; Zacherl M; Wenter V; Winkelmann M; Ricke J; Berger F; Schmid-Tannwald C
    Radiol Oncol; 2023 Dec; 57(4):436-445. PubMed ID: 38038419
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Remodeling of tumor stroma combined with photothermal therapy in the treatment of triple-negative breast cancer].
    Zhang J; Li Y; Tang YX; Wu FY; Wang SJ
    Zhonghua Zhong Liu Za Zhi; 2023 Nov; 45(11):926-933. PubMed ID: 37968077
    [No Abstract]    [Full Text] [Related]  

  • 16. Radiomics in CT and MR imaging of the liver and pancreas: tools with potential for clinical application.
    Berbís MÁ; Godino FP; Rodríguez-Comas J; Nava E; García-Figueiras R; Baleato-González S; Luna A
    Abdom Radiol (NY); 2024 Jan; 49(1):322-340. PubMed ID: 37889265
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Modulation of mammary tumour progression using murine model by ethanol root extract of Saussurea costus (falc.) lipsch.
    Kumar R; Bhardwaj P; Soni M; Singh R; Choudhary S; Virmani N; Asrani RK; Patial V; Sharma D; Gupta VK; Tripathi BN
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117302. PubMed ID: 37858751
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Optimal first-line treatment strategies of systemic therapy for unresectable gastrointestinal neuroendocrine tumors based on the opinions of Japanese experts.
    Honma Y; Ikeda M; Hijioka S; Matsumoto S; Ito T; Aoki T; Furuse J
    Invest New Drugs; 2023 Dec; 41(6):777-786. PubMed ID: 37856005
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Treating rare tumors with liver transplantation.
    Melehy A; Agopian V
    Curr Opin Organ Transplant; 2024 Feb; 29(1):30-36. PubMed ID: 37851086
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification and validation of microtubule depolymerizing agent, CYT997, as a potential drug candidate for hepatocellular carcinoma.
    Ahmad F; Ma L; Wei W; Liu Y; Hakim I; Daugherty A; Mujahid S; Radin AA; Chua MS; So S
    Liver Int; 2023 Dec; 43(12):2794-2807. PubMed ID: 37833852
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 18.